These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. PET/Computed Tomography in the Diagnosis and Staging of Gastric Cancers. Malibari N; Hickeson M; Lisbona R PET Clin; 2015 Jul; 10(3):311-26. PubMed ID: 26099669 [TBL] [Abstract][Full Text] [Related]
8. The use of ¹⁸F-FDG PET/CT in Cowden syndrome to differentiate multifocal gastric carcinoma from extensive benign gastric polyposis. Makis W; Ciarallo A; Hickeson M Clin Nucl Med; 2012 Mar; 37(3):311-4. PubMed ID: 22310267 [No Abstract] [Full Text] [Related]
9. 18F-FDG uptake and its clinical relevance in primary gastric lymphoma. Yi JH; Kim SJ; Choi JY; Ko YH; Kim BT; Kim WS Hematol Oncol; 2010 Jun; 28(2):57-61. PubMed ID: 19593742 [TBL] [Abstract][Full Text] [Related]
10. Spectrum of Physiologic and Pathologic Skeletal Muscle (18)F-FDG Uptake on PET/CT. Karunanithi S; Soundararajan R; Sharma P; Naswa N; Bal C; Kumar R AJR Am J Roentgenol; 2015 Aug; 205(2):W141-9. PubMed ID: 26001118 [TBL] [Abstract][Full Text] [Related]
11. Gastric Carcinosarcoma and 18F-FDG PET/CT. Li B; Zhang Y; Hou J; Cai L; Zhou J; Shi H Clin Nucl Med; 2015 Nov; 40(11):e506-7. PubMed ID: 26359557 [TBL] [Abstract][Full Text] [Related]
12. Performance of (18)F-FDG PET/CT as a postoperative surveillance imaging modality for asymptomatic advanced gastric cancer patients. Lee DY; Lee CH; Seo MJ; Lee SH; Ryu JS; Lee JJ Ann Nucl Med; 2014 Oct; 28(8):789-95. PubMed ID: 24965850 [TBL] [Abstract][Full Text] [Related]
13. Role of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in the characterization of pancreatic masses: experience from tropics. Santhosh S; Mittal BR; Bhasin D; Srinivasan R; Rana S; Das A; Nada R; Bhattacharya A; Gupta R; Kapoor R J Gastroenterol Hepatol; 2013 Feb; 28(2):255-61. PubMed ID: 23278193 [TBL] [Abstract][Full Text] [Related]
14. Impact of incidental findings on integrated 2-[18F]-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography in patients with gastric cancer. Tae CH; Lee JH; Choi JY; Min BH; Rhee PL; Kim JJ Asia Pac J Clin Oncol; 2015 Mar; 11(1):34-40. PubMed ID: 25560093 [TBL] [Abstract][Full Text] [Related]
15. Metastatic Malignant Fibrous Histiocytoma in the Stomach: Imaging With 18F-FDG PET/CT. Fang N; Wang YL; Zeng L; Wu ZJ; Cui XJ Clin Nucl Med; 2016 Feb; 41(2):e123-4. PubMed ID: 26053714 [TBL] [Abstract][Full Text] [Related]
16. Incidental Detection of Urinary Leakage on FDG PET/CT Imaging for Staging of Gastric Cancer. Kim DW; Kim MH; Kim CG Clin Nucl Med; 2016 Mar; 41(3):217-8. PubMed ID: 26571444 [TBL] [Abstract][Full Text] [Related]
17. 18F-FLT PET/CT imaging is not competent for the pretreatment evaluation of metastatic gastric cancer: a comparison with 18F-FDG PET/CT imaging. Zhou M; Wang C; Hu S; Zhang Y; Yao Z; Li J; Guo W; Zhang Y Nucl Med Commun; 2013 Jul; 34(7):694-700. PubMed ID: 23604223 [TBL] [Abstract][Full Text] [Related]
18. A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer. Kauhanen SP; Komar G; Seppänen MP; Dean KI; Minn HR; Kajander SA; Rinta-Kiikka I; Alanen K; Borra RJ; Puolakkainen PA; Nuutila P; Ovaska JT Ann Surg; 2009 Dec; 250(6):957-63. PubMed ID: 19687736 [TBL] [Abstract][Full Text] [Related]
19. Evaluation of thymic tumors with 18F-FDG PET-CT: a pictorial review. Sharma P; Singhal A; Kumar A; Bal C; Malhotra A; Kumar R Acta Radiol; 2013 Feb; 54(1):14-21. PubMed ID: 23377872 [TBL] [Abstract][Full Text] [Related]
20. ¹⁸F-FDG-PET/CT in staging, restaging, and treatment response assessment of male breast cancer. Groheux D; Hindié E; Marty M; Espié M; Rubello D; Vercellino L; Bousquet G; Ohnona J; Toubert ME; Merlet P; Misset JL Eur J Radiol; 2014 Oct; 83(10):1925-33. PubMed ID: 24985086 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]